Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|July 28, 2022
Analysis of FDA's Accelerated Approval Program Performance December 1992-December 2021Ginny Beakes-Read, Madison Neisser, Patrick Frey, et al.Therapeutic Innovation & Regulatory Science|June 2, 2023
Medicinal Product Development and Regulatory Agilities Implemented During the Early Phases of the COVID-19 Pandemic: Experiences and Implications for the Future-An Industry ViewGaia Geraci, Janis Bernat, Céline Rodier, et al.Frontiers in Medicine|August 11, 2023
Walking the talk in digital transformation of regulatory reviewRamy Khalil, Judith C Macdonald, Andrew Gustafson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 22, 2024
Life Years Gained From the FDA Accelerated Approval Program in Oncology: A Portfolio ModelÁgnes Benedict, Gábor Szabó, Kinga Marczell, et al.Journal of Market Access & Health Policy|November 26, 2025
Patient Perspectives on Health Insurance Design: A Mixed-Methods AnalysisBridget Doherty, Kimberly Hooks, Ulrich Neumann, et al.Journal of Market Access & Health Policy|September 11, 2023
Patient perceptions of copay card utilization and policiesDimika Cavalier, Bridget Doherty, Gabrielle Geonnotti, et al.Therapeutic Innovation & Regulatory Science|January 10, 2022
Extrapolation as a Default Strategy in Pediatric Drug DevelopmentMargaret Gamalo, Christina Bucci-Rechtweg, Robert M Nelson, et al.Pageof 1